The role of procalcitonin results in antibiotic decision-making in coronavirus disease 2019 (COVID-19).

ABSTRACT:

Objective

To evaluate the role of procalcitonin (PCT) results in antibiotic decisions for COVID-19 patients at hospital presentation.

Design, setting, and participants

Multicenter retrospective observational study of patients ≥18 years hospitalized due to COVID-19 at the Johns Hopkins Health system. Patients who were transferred from another facility with >24 hours stay and patients who died within 48 hours of hospitalization were excluded.

Methods

Elevated PCT values were determined based on each hospital's definition. Antibiotic therapy and PCT results were evaluated for patients with no evidence of bacterial community-acquired pneumonia (bCAP) and patients with confirmed, probable, or possible bCAP. The added value of PCT testing to clinical criteria in detecting b

SUBMITTER: Fabre V 

PROVIDER: S-EPMC8485015 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature